These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25422695)

  • 1. [Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases].
    Nabih FO; Benali A; Adali I; Manoudi F; Asri F
    Pan Afr Med J; 2014; 18():220. PubMed ID: 25422695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride.
    Angelopoulos P; Markopoulou M; Kyamidis K; Bobotas K
    Gen Hosp Psychiatry; 2008; 30(5):482-4. PubMed ID: 18774435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
    Atbasoglu EC; Ozguven HD; Can Saka M; Goker C
    J Clin Psychiatry; 2004 Dec; 65(12):1724-5. PubMed ID: 15641884
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amisulpride and neuroleptic malignant syndrome.
    Tu MC; Hsiao CC
    Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome.
    Tofler IT; Ahmed B
    J Clin Psychopharmacol; 2003 Dec; 23(6):672-4. PubMed ID: 14624203
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant neuroleptic syndrome associated with amisulpride].
    Harter C; Obier C; Druschky KF; Eikelmann B
    Nervenarzt; 2008 Jan; 79(1):86-9. PubMed ID: 17924089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
    Barrimi M; El Ghazouani F; Zaimi O; Oneib B
    Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome.
    Yasugi S; Garg V; Been G; Magoulas P
    Aust N Z J Psychiatry; 2010 Jun; 44(6):584. PubMed ID: 20482421
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
    Crosby D; Peterson J; Carroll BT
    Ann Clin Psychiatry; 2013 Feb; 25(1):69-70. PubMed ID: 23376873
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
    Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
    Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome.
    Nisijima K; Kusakabe Y; Ohtuka K; Ishiguro T
    Biol Psychiatry; 1998 Nov; 44(9):930-1. PubMed ID: 9807653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catatonia, neuroleptics and brain damage--a case report.
    Chandran M; El-Shazly M
    J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confusion, Rigidity, and Elevated Creatine Phosphokinase: Atypical Neuroleptic Malignant Syndrome Possibly Associated With Clozapine and Sodium Valproate Use.
    Uvais NA; Moideen S; Anver PC
    Prim Care Companion CNS Disord; 2022 Sep; 24(5):. PubMed ID: 36179364
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.
    Ayyıldız H; Turan Ş; Gülcü D; Poyraz CA; Pehlivanoğlu E; Çullu F; Arıkan MK
    Eat Weight Disord; 2016 Jun; 21(2):309-11. PubMed ID: 26607823
    [No Abstract]   [Full Text] [Related]  

  • 17. Lethal neuroleptic malignant syndrome due to amisulpride.
    Musshoff F; Doberentz E; Madea B
    Forensic Sci Med Pathol; 2013 Jun; 9(2):218-20. PubMed ID: 23504701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An atypical case of neuroleptic malignant syndrome precipitated by valproate.
    Verma R; Junewar V; Rathaur BP
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24604797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
    Lin YH; Chien YL
    J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
    Bambrick M; Wilson D
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():377-81. PubMed ID: 1356040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.